Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised Hosts
Louis Nevejan(AZ Sint-Jan), Emmanuel André(KU Leuven), Charlotte Michel(Université Libre de Bruxelles), Lien Cattoir(Onze Lieve Vrouwziekenhuis Hospital), Veerle Matheeussen(University of Antwerp), Hélène Boogaerts(Antwerp University Hospital), Sien Ombelet(KU Leuven), Els Keyaerts(Rega Institute for Medical Research), Koen Magerman, Marijke Reynders, Thomas Demuyser(Vrije Universiteit Brussel), Oriane Soetens(Redeemer's University), Els Van Nedervelde(Vrije Universiteit Brussel), Lize Cuypers(KU Leuven), Dieter Geysels(ZNA Middelheim Hospital), Anton Evenepoel(AZ Sint-Jan), Steven Martens(Onze Lieve Vrouwziekenhuis Hospital), Jorn Hellemans(AZ Sint-Jan), Reinout Naesens(Ziekenhuisnetwerk Antwerpen Stuivenberg), Katrien Lagrou(KU Leuven), Merijn Vanhee(AZ Sint-Jan), Justine Maes(Jessa Hospital), Walter Verstrepen(ZNA Middelheim Hospital), Lucie Seyler(Universitair Ziekenhuis Brussel), Elise Mathieu(Université Libre de Bruxelles), Lies Laenen(Rega Institute for Medical Research)
Cited by 27
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
|Clinical Microbiology and Infection|2011|752